A detailed history of Pfg Investments, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 24,095 shares of SRPT stock, worth $3.66 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
24,095
Previous 19,485 23.66%
Holding current value
$3.66 Million
Previous $1.88 Billion 66.02%
% of portfolio
0.19%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$93.7 - $141.53 $431,957 - $652,453
4,610 Added 23.66%
24,095 $3.12 Billion
Q4 2023

Jan 17, 2024

SELL
$67.31 - $124.76 $137,648 - $255,134
-2,045 Reduced 9.5%
19,485 $1.88 Billion
Q3 2023

Nov 06, 2023

BUY
$102.5 - $123.59 $112,750 - $135,949
1,100 Added 5.38%
21,530 $2.61 Billion
Q2 2023

Aug 03, 2023

BUY
$106.4 - $157.19 $114,380 - $168,979
1,075 Added 5.55%
20,430 $2.34 Billion
Q1 2023

May 11, 2023

BUY
$117.53 - $155.99 $2.27 Million - $3.02 Million
19,355 New
19,355 $2.67 Billion

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $13.3B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.